Brief: NanoRepro Completes Comparative Study, Says Its Tests Detect Omicron
15/02/2022 12:44
Feb 15 (Reuters) - NanoRepro AG NN6G.DE :
* COMPARATIVE STUDY COMPLETED BY RENOWNED UNIVERSITY.
VIROMED /
NANOREPRO DETECTS OMIKRON
* COMPARATIVE EVALUATION OF THE VIROMED / NANOREPRO
SARS-COV-2
ANTIGEN RAPID TEST WITH OTHER RAPID TESTS REGARDING THE
DETECTION OF OMICRON WAS PERFORMED
* RESULTS USING THE EXAMPLE OF RAPID TEST FROM VIROMED /
NANOREPRO
SHOW THAT ALL SAMPLES ACHIEVE GOOD SENSITIVITY IN THE CT RANGES
UP TO 20 AND DETECT OMIKRON
Source text for Eikon: ID:nEQbC1xp3a
Further company coverage: NN6G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on NanoRepro AG
See all newsBrief: NanoRepro Enters Market For Diabetes Diagnostics
Brief: NanoRepro FY Profit After Taxes At EUR 29.7 Mln
Brief: Nanorepro Announces Talks With Viromed Group On Integration Of Individual Business Units Terminated For The Time Being
Brief: NanoRepro Completes Comparative Study, Says Its Tests Detect Omicron
Brief: NanoRepro - Change In Forecast 2021 And Outlook 2022 With Dividend